Insmed Incorporated

Commercial biopharma focused on serious respiratory and rare diseases, led by BRINSUPRI and ARIKAYCE with additional Phase 3 pulmonary programs.

Back to company catalog

Respiratory & rare disease · Small molecules, inhaled therapies & gene therapy · Commercial + Phase 3

Compare report options